NanoViricides Discusses Its Development Program For NV-387, Has Shown Activity Against Many Respiratory Viral Infections In Animal Models, Enabling Human Clinical Trials For A Number Of Indications
NanoViricides, Inc. Discusses its development program for NV-387, a single drug that has shown activity against respiratory viral infections in animal models. The company is a global leader in broad-spectrum antiviral nanomedicines. There are several viruses that continue to cause epidemics in humans.
Benzinga · 3d ago
Weekly Report: what happened at NNVC last week (0701-0705)?
Weekly Report · 6d ago
Weekly Report: what happened at NNVC last week (0624-0628)?
Weekly Report · 07/01 11:59
Weekly Report: what happened at NNVC last week (0617-0621)?
Weekly Report · 06/24 12:09
Why Jabil Shares Are Trading Lower By 8%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Shares of Jabil Inc. Fell 7.8% to $116.37 on Thursday. Jabil reported third-quarter fiscal 2024 revenue of $6.77 billion, down 20.2% year-on-year. MGO Global, Inc. Shares jumped 222.8%.
Benzinga · 06/20 17:26
12 Health Care Stocks Moving In Thursday's Intraday Session
Molecular Partners stock rose 39.1% to $11.07 during Thursday's regular session. Zentalis Pharma (NASDAQ:ZNTL) shares rose 36.83% during the session. Femasys stock increased by 28.27% and SeaStar Medical Holding shares rose 18.68%.
Benzinga · 06/20 16:32
Weekly Report: what happened at NNVC last week (0610-0614)?
Weekly Report · 06/17 11:57
Why AMMO Shares Are Trading Lower By Over 19%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Shares of AMMO, Inc. (NASDAQ:POWW) fell sharply during Friday's session. AMMO reported a fourth-quarter profit of 1 cent per share. The company reported quarterly sales of $40.42 million. Kaival Brands Innovations Group, Inc (KAVL) shares jumped 345% to $6.06.
Benzinga · 06/14 18:13
12 Health Care Stocks Moving In Friday's Intraday Session
Cyclerion Therapeutics shares moved upwards by 37.4% to $2.9 during Friday's regular session. Disc Medicine (NASDAQ:IRON) shares increased by 17.59% during the regular session to $46.05. CNS Pharma stock rose 35.86% and Nexalin Technology stock fell 36.2% on Friday.
Benzinga · 06/14 16:31
12 Health Care Stocks Moving In Wednesday's Intraday Session
Longeveron (NASDAQ:LGVN) shares rose 112.1% to $1.74 during Wednesday's regular session. VTv Therapeutics stock increased by 43.09% to $26.0. Avidity Biosciences shares increased by 32.32% during the session. ThermoGenesis Holdings shares fell 31.4% in the same session.
Benzinga · 06/12 16:31
NanoViricides' NV-387 Results Show Flat Blood Concentration Profile For Prolonged Antiviral Effect In Clinical Trials
Benzinga · 06/11 10:43
12 Health Care Stocks Moving In Monday's Intraday Session
Seres Therapeutics stock moved upwards by 34.0% to $0.82 during Monday's regular session. Renovaro (NASDAQ:RENB) shares increased by 32.51%. Champions Oncology stock increased by 22.82%. Novavax stock decreased by 14.62%.
Benzinga · 06/10 16:31
Weekly Report: what happened at NNVC last week (0603-0607)?
Weekly Report · 06/10 12:01
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
Investorplace · 06/06 11:38
12 Health Care Stocks Moving In Wednesday's After-Market Session
Anitra shares increased by 6.5% to $0.18 during Wednesday's after-market session. PACS Group (NYSE:PACS) shares rose 3.95% during the session. Oragenics (AMEX:OGEN) shares moved upwards by 4.24%. Losers include Concord Medical Services and Theriva Biologics.
Benzinga · 06/05 20:31
12 Health Care Stocks Moving In Tuesday's After-Market Session
Concord Medical Services (NYSE:CCM) shares moved upwards by 131.0% to $4.85 during Tuesday's after-market session. The company's market cap stands at $210.6 million. MAIA Biotechnology (AMEX:MAIA) and Emergent BioSolutions (NYSE) also moved upwards.
Benzinga · 06/04 20:31
NanoViricides Reports On The Highly Desirable Blood Concentration Profile Of Its Lead Clinical Stage Broad-spectrum Antiviral Agent NV-387 Upon Intravenous Administration In A Non-human Primate Animal Model
Lead nanoviricide broad-spectrum antiviral drug candidate NV-387 found to have a flat plateau of blood concentration over 24 hours in a monkey model. Company says the drug increased in a dose-dependent manner in a 24-hour period in the monkeys.
Benzinga · 06/04 11:03
12 Health Care Stocks Moving In Monday's After-Market Session
Gainers FibroGen stock moved upwards by 24.4% to $1.53 during Monday's after-market session. Candel Therapeutics (NASDAQ:CADL) stock increased by 8.12%. Scholar Rock Holding shares rose 6.96% in the after- market. Losers Bright Green and Concord Medical Services stock fell 7.4%.
Benzinga · 06/03 20:31
Weekly Report: what happened at NNVC last week (0527-0531)?
Weekly Report · 06/03 12:04
Weekly Report: what happened at NNVC last week (0520-0524)?
Weekly Report · 05/27 12:10
Webull provides a variety of real-time NNVC stock news. You can receive the latest news about Nanoviricides through multiple platforms. This information may help you make smarter investment decisions.
About NNVC
NanoViricides, Inc. is a development stage company, which is creating special purpose nanomaterials for antiviral therapy. The Company's novel nanoviricide class of drug candidates are designed to specifically attack enveloped virus particles and to dismantle them. Its lead drug candidate is NV-CoV-2 (API NV-387) for the treatment of COVID-19 disease caused by SARS-CoV-2 coronavirus. Its other advanced candidate is NV-HHV-1 for the treatment of Shingles. NV-CoV-2 is its nanoviricide drug candidate for COVID-19 containing the nanoviricide API, NV-387. NV-CoV-2-R is its other drug candidate for COVID-19, which is made up of NV-387 with remdesivir encapsulated within its polymeric micelles. It has developed both of its own drug candidates, NV-CoV-2 and NV-CoV-2-R independently. It is also developing drugs against a number of viral diseases, including RSV, oral and genital Herpes, viral diseases of the eye, including EKC and herpes keratitis, H1N1 swine flu, H5N1 bird flu and others.